Morphological and immunophenotypic features of chronic lymphocytic leukemia

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Chronic lymphocytic leukemia (CLL) is a B-cell malignancy.
• Morphological and immunophenotypic analysis are key diagnostic tools.

Purpose of the Study:

• To review the diagnostic value of morphology and immunophenotype in CLL.
• To correlate these findings with clinical features, genetics, and pathogenesis.

Main Methods:

• Morphological assessment of circulating cells.
• Immunophenotypic profiling using a panel of markers (CD5, CD23, FMC7, sIg, CD22, CD79b).
• Correlation of findings with clinical data and molecular genetics.

Main Results:

• Typical CLL morphology is common, but atypical forms (CLL/PL, 'atypical' CLL) occur in 15% of patients.
• Atypical morphology correlates with advanced disease, poorer survival, and specific genetic abnormalities (e.g., trisomy 12).
• The typical CLL immunophenotype (CD5+, CD23+, FMC7-) aids differentiation from other B-cell malignancies; certain markers (FMC7, CD38) have prognostic value.

Conclusions:

• Morphology and immunophenotype are essential for CLL diagnosis, prognosis, and understanding pathogenesis.
• These investigations provide critical information for patient management.
• Further research into adhesion molecules may elucidate CLL biology.